Pathologic Complete Response After Enfortumab Vedotin Plus Pembrolizumab in Node-positive Upper Tract Urothelial Carcinoma.
Saved in:
| Title: | Pathologic Complete Response After Enfortumab Vedotin Plus Pembrolizumab in Node-positive Upper Tract Urothelial Carcinoma. |
|---|---|
| Authors: | Kikuchi K; Department of Urology, Tokyo Women's Medical University Hospital, Tokyo, Japan., Kobari Y; Department of Urology, Tokyo Women's Medical University Hospital, Tokyo, Japan; yuukikobari17@gmail.com., Nakamura K; Department of Urology, Tokyo Women's Medical University Hospital, Tokyo, Japan., Shibusawa K; Department of Surgical Pathology, Tokyo Women's Medical University Hospital, Tokyo, Japan., Ikeda T; Department of Urology, Tokyo Women's Medical University Hospital, Tokyo, Japan., Nakayama T; Department of Urology, Tokyo Women's Medical University Hospital, Tokyo, Japan., Fukuda H; Department of Urology, Tokyo Women's Medical University Hospital, Tokyo, Japan., Yamamoto T; Department of Surgical Pathology, Tokyo Women's Medical University Hospital, Tokyo, Japan., Yoshida K; Department of Urology, Tokyo Women's Medical University Hospital, Tokyo, Japan., Iizuka J; Department of Urology, Tokyo Women's Medical University Hospital, Tokyo, Japan., Ishida H; Department of Urology, Tokyo Women's Medical University Hospital, Tokyo, Japan., Nagashima Y; Department of Surgical Pathology, Tokyo Women's Medical University Hospital, Tokyo, Japan., Takagi T; Department of Urology, Tokyo Women's Medical University Hospital, Tokyo, Japan. |
| Source: | In vivo (Athens, Greece) [In Vivo] 2026 May-Jun; Vol. 40 (3), pp. 1796-1802. |
| Publication Type: | Journal Article; Case Reports |
| Journal Info: | Publisher: International Institute of Anticancer Research Country of Publication: Greece NLM ID: 8806809 Publication Model: Print Cited Medium: Internet ISSN: 1791-7549 (Electronic) Linking ISSN: 0258851X NLM ISO Abbreviation: In Vivo Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
